CAS: 13246-02-1; [1-Butoxy-3-(5-Ethyl-2,4,6-Trioxo-5-Phenyl-1,3-Diazinan-1-yl)Propan-2-Yl] Carbamate

上下游产品

CAS号870-30-4 PHOSPHORIS°CYAN... | CAS号67441-96-7 1-(3-butoxy-2-h... | CAS号1189-71-5 氯磺酰异氰酸酯 | CAS号73722-81-3 1-chloro-3-buto... | CAS号57-30-7 苯巴比妥钠

📜1-Chloro-3-Butoxy-2-Carbamoyloxypropane,Phenobartital Sodium置于苄基三乙基氯化铵体系中,化学反应 3.0H,以6.21 Mmol的收率获得非巴氨酯
参考文献:N-Alkylation Of Phenobarbital Under Phase-Transfer Catalysis Conditions
标题:N-Alkylation Of Phenobarbital Under Phase-Transfer Catalysis Conditions
摘要:This Communication Describes A Convenient Procedure For The Preparation Of Alkylated Derivatives Of Phenobarbital Using Phase-Transfer Catalysis Without Solvent Conditions.
Doi:10.1080/00397919308018596

专利信息

专利号:WO-9837900-A1
优先权日:1997-02-28
标 题 :Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control
发明人：STUNZENAS VIRMANTAS
权利人:STUNZENAS VIRMANTAS
摘要:This invention is devoted to use of ribonucleic acids in medicinal substances including compositions, vaccines, transplants, intended for medical treatment, prophylactic treatment, cosmetic care; to injection of these substances into patient's organism. So it is possible to introduce ferments, hormones, antibiotics, proteins of cell receptors, structural proteins directly into cells of an organism. It is possible to introduce ribosomal and transport RNAs together with messenger RNA. When there is introduced RNA coding particular hormone or antibiotic, proteins of cell receptor or structural proteins, into recipient's organism, these substances will be synthesized directly in recipient's cells. Use of RNA instead of protein combinations gains an advantage over other analogues already by the fact that the RNA has no immunogenic properties and therefore causes no unwanted inflammatory reactions. RNA is used to supplement vaccine or another substance which is intended to activate patient's immunity against antigens existing in said substance, having removed from said substances or inactivated beforehand part or all the RNA taking part in synthesis of immunogenic substances against which it is wanted to activate patient's immunity.

专利号:US-2008214827-A1
优先权日:2004-02-03
标 题:Synthesis of Cyanoimino-Benzoimidazoles
发明人：GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
权利人:EURO CELTIQUE SA
摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

专利号:US-9968097-B2
优先权日:2012-05-30
标题:Composition comprising a biological control agent and a fungicide selected from inhibitors of the lipid membrane synthesis, the melanine biosynthesis, the nucleic acid synthesis or the signal transduction
发明人：WACHENDORFF-NEUMANN ULRIKE; ANDERSCH WOLFRAM; STENZEL KLAUS; SPRINGER BERND
权利人:BAYER CROPSCIENCE AG
摘要:The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.

专利号:US-6030613-A
优先权日:1995-01-17
标题:Receptor specific transepithelial transport of therapeutics
发明人：BLUMBERG RICHARD S; SIMISTER NEIL E; LENCER WAYNE I
权利人:BRIGHAM & WOMENS HOSPITAL; UNIV BRANDEIS
摘要:The present invention relates in general to methods and products for initiating an immune response against an antigen, and in particular relates to transepithelial delivery of antigens to provoke tolerance and immunity. The present invention further relates to methods and products for the transepithelial delivery of therapeutics. In particular, the invention relates to methods and compositions for the delivery of therapeutics conjugated to a FcRn binding partner to intestinal epithelium, mucosal epithelium and epithelium of the lung. The present invention further relates to the synthesis, preparation and use of the FcRn binding partner conjugates as, or in, pharmaceutical compositions for oral systemic delivery of drugs and vaccines.

专利号:US-2008312325-A1
优先权日:1989-07-28
标题 :Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
发明人：KENNEDY JAMES C; POTTIER ROY H; REID ROBERT L; SAC-MORALES ARNOLD; TOMALTY LEWIS L
权利人:UNIV KINGSTON
摘要:Methods of detecting and treating rapidly growing exogenous cells, such as Protista , or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.

专利号:US-2004110819-A1
优先权日:1991-10-28
标题 :Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
发明人：KENNEDY JAMES C; POTTIER ROY H
权利人:UNIV KINGSTON
摘要:Methods of detecting and treating rapidly growing exogenous cells, such as Protista, or parasites, that preferentially accumulate a photoactivatable porphyrin in which 5-aminolevulinic acid or precursor thereof is administered to the patient, or contacted to the exogenous cells, in an amount sufficient to induce synthesis fluorescence and/or photosensitizing concentrations of a protoporphyrin IX in the exogenous cells, followed by exposure of the exogenous cells to light of photoactivating wavelengths.